Encompass Health Corporation Common Stock (EHC) fair value

ACCE thesis

Encompass Health runs inpatient rehabilitation hospitals and home health and hospice agencies, with its rehab hospital network forming the core of the business. Its structural edge is scale in a niche where certificate-of-need rules and the cost of building new hospitals limit competition, and the company's 25.0% return on equity points to strong returns on that capital. Growth is coming from the aging US population, which feeds steady demand for post-acute rehab, and from continued bed additions and hospital openings. Revenue is growing 9.6% with an 18.1% operating margin, and the stock trades at 19.1x forward earnings, a modest premium to a 21.4x trailing multiple that implies earnings are expected to rise. Worth a deeper look to test whether reimbursement policy and labor costs will keep margins intact as volumes grow.